about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerDietary antioxidants and prostate cancer: a reviewGSTP1 Ile105Val polymorphism and prostate cancer risk: evidence from a meta-analysisEffects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancerImpact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancerFour microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitroPatient and spouse illness beliefs and quality of life in prostate cancer patients.Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells.Which coping strategies can predict beneficial feelings associated with prostate cancer?Experiences of partners of prostate cancer survivors: A qualitative study.Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo.Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells.The impact of educational sessions provided on prostate cancer, and its screening tests on the knowledge level, and participation behavior of the individuals in questionnaire surveys.Cyclin D1 expression in prostate carcinoma.Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.Symptom self-management strategies in patients with non-metastatic prostate cancer.Prostatectomy: information provision and education for patients.
P2860
Q26738703-4E3DBD3C-CADE-4904-A3BD-3D0974BBCEEAQ26996474-4BB3BAA5-A574-4C66-9DE5-E8F31E389139Q28681793-0F4619C3-DC7F-4023-ACF9-AE9B6821375AQ33787995-5AC47558-690A-4338-8326-42A5AF52DDA8Q34427364-F86276BA-DAA7-4245-98C4-62F9C59D873AQ35010133-0817AE92-CF53-4C46-AEAB-E6B5D54303BEQ35193928-E33081F5-D951-49E3-A103-000F96525F3EQ37260986-665FD506-E65F-45BA-98C4-11D81F419065Q38559696-A812EF04-2060-4602-BB0C-035DF6CFF384Q38785357-BCF489A2-2787-472C-8243-99FDD8AEE8CBQ38910658-5F376767-352C-41B5-A18E-89F51BF83DB1Q39079692-9807B235-9DF8-4FB8-9892-468E5152CC9BQ40586584-ADAF2B31-8CCF-4D6A-8A1F-836E1018751CQ41867916-8C53B105-EF2E-4096-934B-A84CEEB2FFAFQ42139633-8E812E89-D111-4C93-AD8B-AA2B90DB1044Q44235274-516A8A6C-91DC-4EAD-93D0-96D9C6688C36Q47699361-9B773CFF-6920-4C01-BC60-922F2FEE965C
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prostate cancer overview.
@en
Prostate cancer overview.
@nl
type
label
Prostate cancer overview.
@en
Prostate cancer overview.
@nl
prefLabel
Prostate cancer overview.
@en
Prostate cancer overview.
@nl
P1476
Prostate cancer overview.
@en
P2093
Mary Weinstein Dunn
Meredith Wallace Kazer
P304
P356
10.1016/J.SONCN.2011.07.002
P577
2011-11-01T00:00:00Z